Bikash Chatterjee's guide to lean manufacturing, six sigma and operational excellence in the pharmaceutical and biotech industries explores how these techniques can be applied across every aspect of the business; from the earliest processes of project selection through the clinical trial process, ma..
Brand Planning for the Pharmaceutical Industry is a step-by-step guide, with examples from the pharmaceutical industry directly applicable to your own brand planning. It begins by exploring the definition of branding and why it is of importance, particularly to the pharmaceutical sector. It shows ho..
Brand Planning for the Pharmaceutical Industry is a step-by-step guide, with examples from the pharmaceutical industry directly applicable to your own brand planning. It begins by exploring the definition of branding and why it is of importance, particularly to the pharmaceutical sector. It shows ho..
In recognition of the sparse information available to practitioners in the field of business development, Martin Austin has drawn on his 30 years of experience in the pharmaceutical industry to provide this highly practical guide spanning the complete process. Based on the well-established training ..
Scientific communication is challenging, conclusions are rarely clear cut making communicating statistical risk and probability tough, especially to non-statisticians and non-scientists such as journalists. In this book John Clare illustrates how to communicate clearly the risks and benefits contai..
This book examines the nature and extent of competition in the pharmaceutical industry and analyses the interaction between market structure and selected elements of the marketing mix...
Darwin’s Medicine examines how pharmaceutical, medical technology and other companies are adapting their strategies, structures, capabilities and other aspects of their business model. In this sequel to his successful The Future of Pharma (Gower, 2011), Brian Smith takes a global perspective, reflec..
Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern ..
This is a practical overview and resource guide for the design and measurement of pharmaceutical relationship marketing (RM) programs. It contains descriptions of each aspect of pharmaceutical RM design and measurement, including a running case study with follow-up exercises. The author has also con..
Blending the authors’ considerable experiences with those of interviewees and with their retrospective and forward-looking perspectives, this volume explains how to apply Knowledge Management in a variety of environments in order to achieve improved efficiency, better decision making and enhanced in..
Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st century. At the same time, the book offers a cautionary evaluation of the future financing of i..
Vast global resources are ploughed into the delivery of treatment interventions ranging from diet and lifestyle advice to complex surgery. In all cases, whatever the intervention, unless the recipient is engaged with the process and understands why the intervention has been offered and the part they..